14th and G Podcast

Trump’s Medicare stance breaks GOP orthodoxy days before Iowa

Donald Trump’s sudden proposal to let Medicare negotiate drug prices broke with longtime Republican orthodoxy on the eve of the Iowa caucuses and alarmed the pharmaceutical industry that’s fought Democrats over this approach for well over a decade. PhRMA said Trump’s plan would drive up insurance prices and jeopardize seniors’ access to life-saving medicines. AHIP, the main health insurance industry lobby, put aside its feud with PhRMA over the rising cost of drugs long enough to reject “this blunt approach to price negotiation.”